NSAIDs & Cannabis - Steph Flashcards
characteristics of protective inflammatory events
- localized, self limiting
- quick resolution
what are some cases in which inflammation is harmful
- misdirection (allergies, autoimmune disease)
- failure to be self limiting (chronic inflammation, fibrosis)
primary tissues of inflammation
blood vessels: allow migration and extravasation of WBC to site of injury
white blood cells: release inflammatory molecules
pain associated with inflammation is caused by
inflammatory mediators, drop in tissue pH, stimulate nociceptors in tissue
2 arachidonic acid metabolites that are also inflammatory mediators
protaglandins, leukotrienes
production of arachidonic acid
- released from membrane phospholipids by action of phospholipases
- AA mediators synthesized by cyclooxygenases and lipoxygenases (produce leukotrienes and lipoxins)
function of prostaglandins (PGD2 PGE2)
- vasodilation and increased vascular permeability
- inflammation, pain, fever
function of prostacyclin
- vasodilation
- inhibits clotting
funtion of thromboxane
- vasoconstriction and promotes clotting
and imbalance between ______ and _______ promotes thrombus formation
An imbalance between prostacyclin and thromboxane
promotes thrombus formation.
what do NSAID drugs act on?
COX 1 and 2 (cyclooeygenase) enzymes to inhibit prostaglandin production
COX1
- constitutive
- produces protanoids with homeostatic function
- gastric mucosa: increases mucus production, enhances local blood flow
- kidneys: maintains adequate. renal perfusion
- platelets: generates thromboxane, increases plateket activation
COX 2
- primarily induced by inflammatory cytokines
- produces prostanoids associated with inflammation, fever and pain
- gastric mucosa: once damaged, plays important role in ulcer healing
- kidney: plays a role in maintaining adequate renal perfusion
- platelets: generates protacyclin, decreases platelet activation
are COX 1 and COX 2 mutually exclusive
no, the division between constitutive (COX 1) and inducible (COX 2) is not 100%!
characteristics of prostanoids
- mostly autocrine or paracrine –> potent but LOCAL effect
- effect is prostanoid, receptor and location dependant
- short half life
general clinical uses of NSAIDs
- anti-inflammatory
-analgesic - antipyretic
- treatment of septic shock
- antithrombotic
- anticancer in some cases
how does COX inhibition cause an analgesic effect
- cox inhibition reduces the peripheral and central effects of prostaglandins
role of peripheral prostaglandins and how cox inhibition carries out its analgesic effect
peripheral prostaglandins sensitize nociceptors increasing the response to noxious stimuli - COX inhibition reduces the effect of prostaglandins
role of central prostaglandins and how cox inhibition carries out its analgesic effect
COX 1 and 2 expressed in spinal chord
- cox 2 is upregulated in response to peripheral inflammation leading to PGE2 release –> lowers spinal depolarization thresholds –> more frequent action potentials in 2nd order neurons “wind-up”/sensitization to analgesia
COX inhibition: inhibits all these effects
Antipyretic effects through NSAIDs/COX inhibition
- normal: increased PGE due to COX 2 induction in hypothalamus resets the body’s thermal set point
- COX inhibition: decreases PGE –> lowers thermal set point –> reduces fever
3 phases of septic shock
- non progressive - compensatory mechanisms are activated to maintain perfusion of vital organs
- progressive - worsening tissue perfusion and metabolic abnormalities, lactic acidosis due to tissue hypoxia
- irreversible - the body has sustained sufficient cell/tissue damage that even if hemodynamic abnormalities are corrected survival is not possible
how are NSAIDs used in the treatment of septic shock
- improves the clincial parameters in patients with septic shock
- mechanism not fully understood: likely COX inhibition and inhibition of TNF, caspase, and other inflammatory mediators
- NSAIDs DO NOT bind endotoxin
in patients with poor perfusion, what should be considered when using NSAIDs to treat septic shock
benefits of NSAIDs may not outweight the risks in patients with poor perfusion
typical NSAID used to treat septic shock symptoms in cows and horses
flunixin - may help alleviate hemodynamic effects of sepsis (vasodilation,increased vascular permiability, decreased organ perfusion)
how does flunixin help in patients with septic shock symptoms
may help alleviate hemodynamic effects of sepsis (vasodilation,increased vascular permiability, decreased organ perfusion)
how do NSAIDs help in antithrombotic effects
COX-1: mediates thromboxane synthesis - increases platelet activation and aggregation
both non-selective and COX-2 selective NSAIDs have some COX-1 inhibition
Aspirin low dose effects
selectively and irreversibly inhibits COX-1 –> antithrombotic effect
mechanism for NSAID use in anticancer effect
- CoX-2 up regulated in some tumors (transitional cell carcinoma, squamous cell carcinoma, melanoma)
- NSAIDS may supress certain tumors via: restoring apoptosis, inhibit angiogenesis
NSAIDS that have some efficacy against transitional cell carcinoma in dogs
COX 2 inhibitors:
- firocoxib, meloxicam, deracoxib
NSAID that is sometimes used against squamous cell carcinoma in horses
piroxicam (non selective COX inhibitor)
pharmacokinetic properties of NSAIDs
- highly protein bound
- well-absorbed orally
- metabolized in liver
- half-life and dose varies dramatically between species
name the potential adverse effects of NSAIDs
- GI irritation and ulceration
- renotoxicity
- hepatotoxicity
- hemorrhage
- blood dyscrasias
- delayed partuition
- delated soft tissue healing
- delayed fracture healing
describe the mechanism behind the use of NSAIDs on GI irritation/ulceration
- COX 1 has gastroprotective effects
- COX 2 may be involved in healing ulcers
- some NSAIDs are GI irritants - may see GI ulcers in patients who receive IV NSAIDs
inhibition of PGE –> decrease in bicarb and mucous secretion in stomach –> dec. in mucous protective layer
which type of NSAID is less ulcerogenic?
COX-2 selective (but NOTE: GI ulceration has occured after administration of highly COX-2 selective NSAIDs)
in additition to COX inhibition, what are other ulcerogenic effects related to NSAIDs
- direct GI irritation (NSAIDs = weak acids, aspirin precipitates out in acidic environments and may cause physical irritation
- enterohepatic recycling (drug excreted in bile –> resorbed in small intestine –> invreases duodenal and systemic exposure to NSAID)
- prolonged plasma half-life: icreased GI an renal adverse effects
clinical signs of GI irritation/ulceration in dugs
vomitting, melena and inappetance
clinical signs of GI irritation/ulceration in horses
inappetance, colic and diarrhea
most common site of NSAID GI adverse effects in horses
right dorsal common
why is there no NSAIDs labelled for long term use in cats
cats are particularly susceptible to NSAID-induced gastrointestinal ulcers
how do NSAIDs cause renotoxicity
prostaglandins maintain renal bloodflow and glomerular filtration rate in conditions of hypovolemia, hypoatremia and hypotension, in Diabetes mellitus patients and adrenocortical dysfunction
- inhibition of prostaglandins can cause ischemia of renal medulla
- renal papillary necrosis
- can cause acute renal failure during anesthesia or in hypovolemic/dehydrated patients
- COX-2 also crucial for renal development